{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:18:39Z","timestamp":1791289119714,"version":"4.3.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1995,1,1]],"date-time":"1995-01-01T00:00:00Z","timestamp":788918400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[1995,1]]},"DOI":"10.1038\/nm0195-74","type":"journal-article","created":{"date-parts":[[2004,8,19]],"date-time":"2004-08-19T01:04:00Z","timestamp":1092877440000},"page":"74-79","source":"Crossref","is-referenced-by-count":311,"title":["The serum concentration of active transforming growth factor-\u03b2 is severely depressed in advanced atherosclerosis"],"prefix":"10.1038","volume":"1","author":[{"given":"David J.","family":"Grainger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul R.","family":"Kemp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James C.","family":"Metcalfe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander C.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard M.","family":"Lawn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norman R.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew A.","family":"Grace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter M.","family":"Schofield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anoop","family":"Chauhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BFnm019574_CR1","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1056\/NEJM199006073222304","volume":"322","author":"PA Syetkowski","year":"1990","unstructured":"Syetkowski, P.A. et al. Changes in risk factors and the decline in mortality from cardiovascular disease: the Framingham study. New. Engl J. Med. 322, 1635\u20131641 (1990).","journal-title":"New. Engl J. Med."},{"key":"BFnm019574_CR2","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1126\/science.2530631","volume":"246","author":"G Utermann","year":"1989","unstructured":"Utermann, G. The mysteries of lipoprotein (a). Science 246, 904\u2013910 (1989).","journal-title":"Science"},{"key":"BFnm019574_CR3","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1161\/01.CIR.85.6.2025","volume":"85","author":"JJ Genest","year":"1992","unstructured":"Genest, J.J. et al. Familial lipoprotein disorders in patients with premature coronary artery disease. Circulation 85, 2025\u20132033 (1992).","journal-title":"Circulation"},{"key":"BFnm019574_CR4","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1161\/01.ATV.13.6.826","volume":"13","author":"PJ Schreiner","year":"1993","unstructured":"Schreiner, P.J. et al. Lipoprotein (a) as a risk factor for preclinical atherosclerosis. Arterioscl Thromb. 13, 826\u2013833 (1993).","journal-title":"Arterioscl Thromb."},{"key":"BFnm019574_CR5","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S0140-6736(94)90814-1","volume":"343","author":"NJ Wald","year":"1994","unstructured":"Wald, N.J. et al. Apolipoproteins and ischaemic heart disease \u2014 implications for screening. The Lancet 343, 75\u201379 (1994).","journal-title":"The Lancet"},{"key":"BFnm019574_CR6","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1136\/bmj.308.6925.373","volume":"308","author":"MR Law","year":"1994","unstructured":"Law, M.R. et al. Assessing possible hazards of reducing serum cholesterol. Br. med. J. 308, 373\u2013379 (1994).","journal-title":"Br. med. J."},{"key":"BFnm019574_CR7","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1056\/NEJM198512193132501","volume":"313","author":"A Hamsten","year":"1985","unstructured":"Hamsten, A. et al. Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. New. Engl. J. Med. 313, 1557\u20131563 (1985).","journal-title":"New. Engl. J. Med."},{"key":"BFnm019574_CR8","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1136\/hrt.71.6.504","volume":"71","author":"D de Bono","year":"1994","unstructured":"de Bono, D. Significance of raised plasma concentrations of tissue type plasminogen activator and plasminogen activator inhibitor in patients at risk from ischaemic heart disease. Br. Heart J. 71, 504\u2013507 (1994).","journal-title":"Br. Heart J."},{"key":"BFnm019574_CR9","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1056\/NEJM198911093211907","volume":"321","author":"DJ Gordon","year":"1989","unstructured":"Gordon, D.J. & Rifkind, B.M. Current concepts-high density lipoprotein \u2014 the clinical implications of recent studies. New. Engl. J. Med. 321, 1311\u20131316 (1989).","journal-title":"New. Engl. J. Med."},{"key":"BFnm019574_CR10","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/0002-9149(83)90649-5","volume":"52","author":"WB Kannel","year":"1983","unstructured":"Kannel, W.B. High density lipoproteins: epidemiological profile and risks of coronary artery disease. Am. J. Cardiol 52, 9\u201312B (1983.","journal-title":"Am. J. Cardiol"},{"key":"BFnm019574_CR11","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1126\/science.8503012","volume":"260","author":"DJ Grainger","year":"1993","unstructured":"Grainger, D.J. et al. Proliferation of human smooth muscle Cells promoted by lipoprotein (a). Science 260, 1655\u20131658 (1993).","journal-title":"Science"},{"key":"BFnm019574_CR12","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/370460a0","volume":"370","author":"DJ Grainger","year":"1994","unstructured":"Grainger, D.J. et al. Activation of transforming growth factor b is inhibited in apolipoprotein (a) transgenic mice. Nature 370, 460\u2013462 (1994).","journal-title":"Nature"},{"key":"BFnm019574_CR13","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1056\/NEJM197608122950707","volume":"295","author":"R Ross","year":"1976","unstructured":"Ross, R. & Glomset, J.N. The pathogenesis of atherorosclerosis. N. Eng. J. Med. 295, 369\u2013377 (1976).","journal-title":"N. Eng. J. Med."},{"key":"BFnm019574_CR14","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/362801a0","volume":"362","author":"R Ross","year":"1993","unstructured":"Ross, R. The pathogenesis of atherosclerosis : a perspective for the 1990s. Nature 362, 801\u2013809 (1993.","journal-title":"Nature"},{"key":"BFnm019574_CR15","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1083\/jcb.113.6.1439","volume":"113","author":"S Kojima","year":"1991","unstructured":"Kojima, S., Harpel, P.C. & Rifkin, D.B. Lipoprotein (a) inhibits the generation of transforming growth factor b: an endogenenous inhibitor of smooth muscle Cell migration. J. cell Biol. 113, 1439\u20131443 (1991).","journal-title":"J. cell Biol."},{"key":"BFnm019574_CR16","doi-asserted-by":"publisher","first-page":"C571","DOI":"10.1152\/ajpcell.1993.265.2.C571","volume":"265","author":"HL Kirschenlohr","year":"1993","unstructured":"Kirschenlohr, H.L. et al. Adult human aortic smooth muscle Cells in culture produce active TGF-\u03b2. Am. J. Physiol 265, C571\u2013C576 (1993).","journal-title":"Am. J. Physiol"},{"key":"BFnm019574_CR17","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1083\/jcb.106.5.1659","volume":"106","author":"R Lyons","year":"1988","unstructured":"Lyons, R., Keski-Oja, J. & Moses, H.L. Proteolytic activation of latent transforming growth factor-\u03b2 from fibroblast conditioned medium. J. Cell Biol. 106, 1659\u20131665 (1988).","journal-title":"J. Cell Biol."},{"key":"BFnm019574_CR18","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1083\/jcb.110.4.1361","volume":"110","author":"RM Lyons","year":"1990","unstructured":"Lyons, R.M. et al. Mechanisms of activation of latent recombinant transforming growth factor \u03b2 by plasmin. J. Cell Biol. 110, 1361\u20131367 (1990).","journal-title":"J. Cell Biol."},{"key":"BFnm019574_CR19","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/330132a0","volume":"330","author":"JW McLean","year":"1987","unstructured":"McLean, J.W. et al. cDNA sequence of human apolipoprotein (a) is homologous to plasminogen. Nature 330, 132\u2013137 (1987).","journal-title":"Nature"},{"key":"BFnm019574_CR20","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/0076-6879(91)98033-3","volume":"198","author":"DA Lawrence","year":"1991","unstructured":"Lawrence, D.A. Identification and activation of latent transforming growth factor \u03b2. Meth Enzym 198, 327\u2013336 (1991).","journal-title":"Meth Enzym"},{"key":"BFnm019574_CR21","doi-asserted-by":"crossref","unstructured":"Grainger, D. et al. Active and acid-activatable TGF-b in human sera, platelets and plasma. Clin. Chim. Acta (In the press).","DOI":"10.1016\/0009-8981(94)05995-4"},{"key":"BFnm019574_CR22","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1136\/bmj.303.6800.435","volume":"303","author":"CC McDonald","year":"1991","unstructured":"McDonald, C.C. & Stewart, H.J. Fatal myocardial infarction in the Scottish adjuvant tamoxifen trial. Br. med. J. 303, 435\u2013437 (1991).","journal-title":"Br. med. J."},{"key":"BFnm019574_CR23","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/bjc.1990.307","volume":"62","author":"AA Colletta","year":"1990","unstructured":"Colletta, A.A. et al. Antioestrogens induce the secretion of active transforming growth factor-\u03b2 from foetal human fibroblasts. Br. J. Cancer 62, 405\u2013409 (1990).","journal-title":"Br. J. Cancer"},{"key":"BFnm019574_CR24","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1042\/bj2940109","volume":"294","author":"DJ Grainger","year":"1993","unstructured":"Grainger, D.J. et al. decreases the rate of proliferation of rat vascular smooth muscle cells in culture by inducing the production of transforming growth factor-\u03b2. Biochem. J. 294, 109\u2013112 (1993).","journal-title":"Biochem. J."},{"key":"BFnm019574_CR25","first-page":"4261","volume":"52","author":"A Butta","year":"1992","unstructured":"Butta, A. et al. Induction of transforming growth factor-\u03b2 in human breast cancer in vivo following tamoxifen treatment. Cancer Res. 52, 4261\u20134264 (1992).","journal-title":"Cancer Res."},{"key":"BFnm019574_CR26","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/0092-8674(92)90152-3","volume":"68","author":"HY Lin","year":"1992","unstructured":"Lin, H.Y. et al. Expression cloning of the TGF-\u03b2 type II receptor, a functional transmembrane serine\/threonine kinase. Cell 68, 775\u2013786 (1992).","journal-title":"Cell"}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nm0195-74","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm0195-74.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm0195-74.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T23:29:33Z","timestamp":1684452573000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm0195-74"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,1]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1995,1]]}},"alternative-id":["BFnm019574"],"URL":"https:\/\/doi.org\/10.1038\/nm0195-74","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,1]]}}}